NCT02108288View on ClinicalTrials.gov

Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

August 31, 2014

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

OPC-1085EL ophthalmic solution

DRUG

Carteolol long-acting ophthalmic solution

DRUG

Latanoprost ophthalmic solution

Trial Locations (1)

Unknown

Kansai Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY